Literature DB >> 34697193

Radiotherapy Increases the Incidence of Herpes Zoster in Oral Cavity Cancer Patients - a National Population-based Cohort Study.

Yung-Shuo Kao1, Yen Hsu2, Chung Y Hsu3.   

Abstract

BACKGROUND/AIM: Oral cavity cancer is a major health problem worldwide. The herpes zoster vaccine is an effective method to protect against herpes zoster infection. In this study we aimed to determine the relationship between herpes zoster and oral cavity cancer. PATIENTS AND METHODS: The Longitudinal Generation Tracking Database in Taiwan was used to select oral and non-oral cavity cancer patients. The primary endpoint was herpes zoster.
RESULTS: We included 3131 oral cavity cancer patients and 3131 non-oral cavity cancer patients. Patients with oral cavity cancer [adjusted hazard ratio (HR)=1.66, 95% confidence interval (CI)=1.27-2.16] had a significantly higher risk of herpes zoster compared to the control group. The oral cavity patients who received radiotherapy (adjusted HR=1.79, 95%CI=1.12-2.86) had a significantly higher risk of herpes zoster compared to the oral cavity patients who did not receive radiotherapy.
CONCLUSION: Radiotherapy increases the incidence of herpes zoster infection in oral cavity cancer patients.
Copyright © 2021 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Oral cavity cancer; herpes zoster; radiotherapy

Mesh:

Year:  2021        PMID: 34697193      PMCID: PMC8627721          DOI: 10.21873/invivo.12657

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  20 in total

Review 1.  Risk Factors for Herpes Zoster: A Systematic Review and Meta-analysis.

Authors:  Kosuke Kawai; Barbara P Yawn
Journal:  Mayo Clin Proc       Date:  2017-12       Impact factor: 7.616

Review 2.  Epidemiology, treatment and prevention of herpes zoster: A comprehensive review.

Authors:  Elsam Koshy; Lu Mengting; Hanasha Kumar; Wu Jianbo
Journal:  Indian J Dermatol Venereol Leprol       Date:  2018 May-Jun       Impact factor: 2.545

Review 3.  Varicella-zoster virus infection: natural history, clinical manifestations, immunity and current and future vaccination strategies.

Authors:  Giulia Freer; Mauro Pistello
Journal:  New Microbiol       Date:  2018-03-02       Impact factor: 2.479

4.  Vaccination against Herpes Zoster and Postherpetic Neuralgia.

Authors:  Michael N Oxman; Myron J Levin
Journal:  J Infect Dis       Date:  2008-03-01       Impact factor: 5.226

5.  Risk of Herpes zoster in patients with underlying diseases: a retrospective hospital-based cohort study.

Authors:  A Hata; M Kuniyoshi; Y Ohkusa
Journal:  Infection       Date:  2011-07-29       Impact factor: 3.553

6.  Herpes zoster risk after 21 specific cancers: population-based case-control study.

Authors:  Erik Hansson; Harriet J Forbes; Sinéad M Langan; Liam Smeeth; Krishnan Bhaskaran
Journal:  Br J Cancer       Date:  2017-05-02       Impact factor: 7.640

7.  Risk and impact of herpes zoster on patients with diabetes: A population-based study, 2009-2014.

Authors:  Cintia Muñoz-Quiles; Mónica López-Lacort; F Javier Ampudia-Blasco; Javier Díez-Domingo
Journal:  Hum Vaccin Immunother       Date:  2017-11-02       Impact factor: 3.452

8.  Real-world database investigating the association between diabetes mellitus and herpes zoster in Taiwan.

Authors:  Shih-Wei Lai; Cheng-Li Lin; Kuan-Fu Liao
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

9.  Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccines.

Authors:  Kathleen L Dooling; Angela Guo; Manisha Patel; Grace M Lee; Kelly Moore; Edward A Belongia; Rafael Harpaz
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2018-01-26       Impact factor: 17.586

10.  Herpes zoster incidence in Germany - an indirect validation study for self-reported disease data from pretest studies of the population-based German National Cohort.

Authors:  Mahrrouz Caputo; Johannes Horn; André Karch; Manas K Akmatov; Heiko Becher; Bettina Braun; Hermann Brenner; Stefanie Castell; Beate Fischer; Guido Giani; Kathrin Günther; Barbara Hoffmann; Karl-Heinz Jöckel; Thomas Keil; Birgit Klüppelholz; Lilian Krist; Michael F Leitzmann; Wolfgang Lieb; Jakob Linseisen; Christa Meisinger; Susanne Moebus; Nadia Obi; Tobias Pischon; Sabine Schipf; Börge Schmidt; Claudia Sievers; Astrid Steinbrecher; Henry Völzke; Rafael Mikolajczyk
Journal:  BMC Infect Dis       Date:  2019-01-30       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.